- Conditions
- Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +20 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
Clinical trial condition
B Acute Lymphoblastic Leukemia
Explore clinical trials studying B Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.
29 public trials
9 recruiting studies
B Acute Lymphoblastic Leukemia trial results
- Conditions
- B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
NCT03959085
- Conditions
- B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Burkitt Lymphoma, +25 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- USA Health Strada Patient Care Center Mobile, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
NCT03150693
- Conditions
- B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
NCT02877303
- Conditions
- B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Burkitt Lymphoma, +21 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
- Conditions
- Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, +25 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Recruiting
JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia
NCT06940960
- Conditions
- B Acute Lymphoblastic Leukemia, B-Non Hodgkin Lymphoma, Burkitt Lymphoma, +16 more
- Locations
-
- Affiliated Hospital of Guangdong Medical University Guangzhou, Guangdong, China
Recruiting
JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia
NCT06890065
- Conditions
- B Acute Lymphoblastic Leukemia, B-Non Hodgkin Lymphoma, Burkitt Lymphoma, +16 more
- Locations
-
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
NCT05281809
- Conditions
- B Acute Lymphoblastic Leukemia, B-cell Lymphoma, Burkitt Lymphoma, +36 more
- Locations
-
- AHN Cancer Institute - West Penn Hospital Pittsburgh, Pennsylvania, United States
Not Yet Recruiting
Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment
NCT07636564
- Conditions
- Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, +24 more
- Locations
-
Not specified